PARK7 and Parkinson disease: Pharmacogenomic properties and genotype-specific treatment of several other gene mutations in PD such as VPS35 and DJ1 have not yet been characterized fully due to the rarity of cases and are currently a focus of several studies that as of writing do not have preliminary results available [90,115,116].